Abstract
Apolipoprotein CI (ApoCI) is an apolipoprotein mainly present on high-density lipoprotein (HDL) and postprandial on triglyceride-rich lipoproteins (TRLs). ApoCI influences many proteins involved in the remodeling of lipoproteins in plasma [1–6]. In addition, ApoCI inhibits the ApoE-mediated binding of VLDL and chylomicrons to the LDL receptor and to the LDL receptor-related protein (LRP) [7]. Recently, an important role of ApoCI in the modulation of the inflammatory response was revealed in vitro and in mice [8].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
